ATE337826T1 - Simplifizierte sarcodictyn-derivate als anti- tumor-mittel - Google Patents

Simplifizierte sarcodictyn-derivate als anti- tumor-mittel

Info

Publication number
ATE337826T1
ATE337826T1 AT02772277T AT02772277T ATE337826T1 AT E337826 T1 ATE337826 T1 AT E337826T1 AT 02772277 T AT02772277 T AT 02772277T AT 02772277 T AT02772277 T AT 02772277T AT E337826 T1 ATE337826 T1 AT E337826T1
Authority
AT
Austria
Prior art keywords
derivatives
simplified
sarcodictyn
tumor agents
sarcodictyin
Prior art date
Application number
AT02772277T
Other languages
English (en)
Inventor
Nicola Mongelli
Maria Menichincheri
Marina Ciomei
Cesare Gennari
Joachim Telser
Raphael Beumer
Original Assignee
Pfizer Italia Srl
Univ Degli Studi Milano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Italia Srl, Univ Degli Studi Milano filed Critical Pfizer Italia Srl
Application granted granted Critical
Publication of ATE337826T1 publication Critical patent/ATE337826T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/32—All rings being cycloaliphatic the ring system containing at least eleven carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT02772277T 2001-09-14 2002-09-06 Simplifizierte sarcodictyn-derivate als anti- tumor-mittel ATE337826T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0122257.9A GB0122257D0 (en) 2001-09-14 2001-09-14 Simplified sarcodictyin derivatives

Publications (1)

Publication Number Publication Date
ATE337826T1 true ATE337826T1 (de) 2006-09-15

Family

ID=9922112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02772277T ATE337826T1 (de) 2001-09-14 2002-09-06 Simplifizierte sarcodictyn-derivate als anti- tumor-mittel

Country Status (11)

Country Link
US (1) US20050038112A1 (de)
EP (1) EP1439885B1 (de)
JP (1) JP2005519864A (de)
AT (1) ATE337826T1 (de)
CA (1) CA2460244A1 (de)
DE (1) DE60214412T2 (de)
DK (1) DK1439885T3 (de)
ES (1) ES2269768T3 (de)
GB (1) GB0122257D0 (de)
PT (1) PT1439885E (de)
WO (1) WO2003024529A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107337671A (zh) * 2016-12-31 2017-11-10 陕西科技大学 一类具有抗肿瘤活性的橙皮素氮杂肉桂酸酯化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9509888D0 (en) * 1995-05-16 1995-07-12 Pharmacia Spa Terpenoidic derivatives useful as antitumour agents
US5965718A (en) * 1997-10-24 1999-10-12 The Scripps Research Institute Analogs of sarcodictyin and eleutherobin

Also Published As

Publication number Publication date
US20050038112A1 (en) 2005-02-17
PT1439885E (pt) 2007-01-31
ES2269768T3 (es) 2007-04-01
DE60214412D1 (de) 2006-10-12
DE60214412T2 (de) 2007-09-20
WO2003024529A1 (en) 2003-03-27
GB0122257D0 (en) 2001-11-07
EP1439885A1 (de) 2004-07-28
DK1439885T3 (da) 2007-01-08
EP1439885B1 (de) 2006-08-30
CA2460244A1 (en) 2003-03-27
JP2005519864A (ja) 2005-07-07

Similar Documents

Publication Publication Date Title
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
MXPA06000302A (es) Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
TW200505924A (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
TW200407326A (en) Pyrimido compounds having antiproliferative activity
ATE396986T1 (de) Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken
NO20054842L (no) Kjemiske forbindelser
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
PL374443A1 (en) Novel pyrimidineamide derivatives and the use thereof
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
NO20055891L (no) Kinazolinderivater som aurorakinaseinhibitorer
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
WO2002070515A3 (en) Chromane derivatives, process for their preparation and their use as antitumor agents
ATE326451T1 (de) Chinazolin derivate und therapeutische verwendungen davon
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
DE60221104D1 (de) Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose
DE60214412D1 (de) Simplifizierte sarcodictyn-derivate als anti-tumor-mittel
TW200505913A (en) Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
PL1668021T3 (pl) Nowe związki tioksylozy, sposób ich przygotowania, zawierające je kompozycje farmaceutyczne i ich zastosowanie w lecznictwie
MXPA05011671A (es) Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos.
TW200736220A (en) Pyridylsulfonamide derivatives, their manufacture and use as pharmaceutical agents
TW200720239A (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
TW200612914A (en) Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
TW200602329A (en) Novel diazine derivatives, their manufacture and use as pharmaceutical agents
TW200633701A (en) Thioether derivatives, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1439885

Country of ref document: EP

REN Ceased due to non-payment of the annual fee